Academic Journal
A phase I trial of palbociclib and bosutinib with fulvestrant in patients with metastatic hormone receptor positive and HER2 negative (HR+ HER2-) breast cancer refractory to an aromatase inhibitor and a CDK4/6 inhibitor
العنوان: | A phase I trial of palbociclib and bosutinib with fulvestrant in patients with metastatic hormone receptor positive and HER2 negative (HR+ HER2-) breast cancer refractory to an aromatase inhibitor and a CDK4/6 inhibitor |
---|---|
المؤلفون: | Roy, Tina, Barrows, Elizabeth, Mainor, Candace, Collins, Julie, Lynce, Filipa, Isaacs, Claudine, Pohlmann, Paula R. |
المصدر: | Contemporary Clinical Trials Communications ; volume 33, page 101110 ; ISSN 2451-8654 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2023 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/j.conctc.2023.101110 |
الاتاحة: | http://dx.doi.org/10.1016/j.conctc.2023.101110 https://api.elsevier.com/content/article/PII:S245186542300056X?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S245186542300056X?httpAccept=text/plain |
Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/ |
رقم الانضمام: | edsbas.9BC142D9 |
قاعدة البيانات: | BASE |
DOI: | 10.1016/j.conctc.2023.101110 |
---|